RPL554: Ph IIa started

Verona began a double-blind, placebo-controlled, 3-way crossover, U.K. Phase IIa trial to evaluate

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE